Matches in SemOpenAlex for { <https://semopenalex.org/work/W2771654882> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2771654882 endingPage "718" @default.
- W2771654882 startingPage "718" @default.
- W2771654882 abstract "(Background) Previous studies have demonstrated the safety of ABO-incompatible living donor liver transplantation (LDLT) using preoperative plasmapheresis and rituximab. However, no reports have so far described the timing and dosage of rituximab administration for pediatric LDLT. The aim of this study is to determine the optimal dosage and timing of rituximab treatment in patients undergoing pediatric ABO-incompatible LDLT. (Methods) Between May 2001 and July 2013, 222 LDLTs were performed for 217 patients. Emergency LDLTs were excluded, because there was not adequate time to prepare these patients for ABO-incompatible LDLT. Those cases included 32 ABO-incompatible LDLTs in 31 patients, and 12 cases (11 patients) were administered rituximab. The anti-ABO antibody titers were reduced preoperatively by plasmapheresis in all cases who were administered rituximab. Rituximab was used from January 2004 for recipients over two years of age (first period; 375 mg/m2 two weeks before LDLT in two cases, second period; 50 mg/m2 two weeks before LDLT in two cases and third period: 200 mg/m2 three weeks before LDLT in eight cases). (Results) The ABO-incompatible LDLT recipient survival rate (87.1%) was significantly lower than that of the other recipients (97.3%) (p=0.008). Two patients who were administered 375 mg/m2 of rituximab died of Pneumocystis jiroveci pneumonia and hemophagocytic syndrome, respectively. One patient who was administered 50 mg/m2 of rituximab underwent re-transplantation due to antibody-mediated complications (intrahepatic biliary strictures). All eight patients who were administered 200 mg/m2 of rituximab survived. The mean CD20+ lymphocyte count was 0.1% at the time of LDLT and 5.4% six months after LDLT. (Conclusion) In the preoperative management of patients undergoing pediatric ABO-incompatible LDLT, the administration of 200 mg/m2 of rituximab three weeks before LDLT is optimally safe and effective." @default.
- W2771654882 created "2017-12-22" @default.
- W2771654882 creator A5005163574 @default.
- W2771654882 creator A5014297655 @default.
- W2771654882 creator A5018139084 @default.
- W2771654882 creator A5018342260 @default.
- W2771654882 creator A5021522402 @default.
- W2771654882 creator A5024124710 @default.
- W2771654882 creator A5029327077 @default.
- W2771654882 creator A5030549359 @default.
- W2771654882 creator A5033428883 @default.
- W2771654882 creator A5052452024 @default.
- W2771654882 creator A5054908894 @default.
- W2771654882 creator A5057933806 @default.
- W2771654882 creator A5065211925 @default.
- W2771654882 creator A5068691626 @default.
- W2771654882 date "2014-07-01" @default.
- W2771654882 modified "2023-09-23" @default.
- W2771654882 title "How to Use Rituximab in ABO-Incompatible Pediatric Living Donor Liver Transplantation: A Single Center Experience." @default.
- W2771654882 doi "https://doi.org/10.1097/00007890-201407151-02442" @default.
- W2771654882 hasPublicationYear "2014" @default.
- W2771654882 type Work @default.
- W2771654882 sameAs 2771654882 @default.
- W2771654882 citedByCount "0" @default.
- W2771654882 crossrefType "journal-article" @default.
- W2771654882 hasAuthorship W2771654882A5005163574 @default.
- W2771654882 hasAuthorship W2771654882A5014297655 @default.
- W2771654882 hasAuthorship W2771654882A5018139084 @default.
- W2771654882 hasAuthorship W2771654882A5018342260 @default.
- W2771654882 hasAuthorship W2771654882A5021522402 @default.
- W2771654882 hasAuthorship W2771654882A5024124710 @default.
- W2771654882 hasAuthorship W2771654882A5029327077 @default.
- W2771654882 hasAuthorship W2771654882A5030549359 @default.
- W2771654882 hasAuthorship W2771654882A5033428883 @default.
- W2771654882 hasAuthorship W2771654882A5052452024 @default.
- W2771654882 hasAuthorship W2771654882A5054908894 @default.
- W2771654882 hasAuthorship W2771654882A5057933806 @default.
- W2771654882 hasAuthorship W2771654882A5065211925 @default.
- W2771654882 hasAuthorship W2771654882A5068691626 @default.
- W2771654882 hasConcept C126322002 @default.
- W2771654882 hasConcept C141071460 @default.
- W2771654882 hasConcept C159654299 @default.
- W2771654882 hasConcept C176080213 @default.
- W2771654882 hasConcept C203014093 @default.
- W2771654882 hasConcept C2778842783 @default.
- W2771654882 hasConcept C2779338263 @default.
- W2771654882 hasConcept C2779609443 @default.
- W2771654882 hasConcept C2780073493 @default.
- W2771654882 hasConcept C2780653079 @default.
- W2771654882 hasConcept C2911091166 @default.
- W2771654882 hasConcept C71924100 @default.
- W2771654882 hasConcept C90924648 @default.
- W2771654882 hasConceptScore W2771654882C126322002 @default.
- W2771654882 hasConceptScore W2771654882C141071460 @default.
- W2771654882 hasConceptScore W2771654882C159654299 @default.
- W2771654882 hasConceptScore W2771654882C176080213 @default.
- W2771654882 hasConceptScore W2771654882C203014093 @default.
- W2771654882 hasConceptScore W2771654882C2778842783 @default.
- W2771654882 hasConceptScore W2771654882C2779338263 @default.
- W2771654882 hasConceptScore W2771654882C2779609443 @default.
- W2771654882 hasConceptScore W2771654882C2780073493 @default.
- W2771654882 hasConceptScore W2771654882C2780653079 @default.
- W2771654882 hasConceptScore W2771654882C2911091166 @default.
- W2771654882 hasConceptScore W2771654882C71924100 @default.
- W2771654882 hasConceptScore W2771654882C90924648 @default.
- W2771654882 hasLocation W27716548821 @default.
- W2771654882 hasOpenAccess W2771654882 @default.
- W2771654882 hasPrimaryLocation W27716548821 @default.
- W2771654882 hasRelatedWork W1964145194 @default.
- W2771654882 hasRelatedWork W1971542954 @default.
- W2771654882 hasRelatedWork W1984100884 @default.
- W2771654882 hasRelatedWork W2020666825 @default.
- W2771654882 hasRelatedWork W2022112797 @default.
- W2771654882 hasRelatedWork W2036975756 @default.
- W2771654882 hasRelatedWork W2130154522 @default.
- W2771654882 hasRelatedWork W2151448166 @default.
- W2771654882 hasRelatedWork W2962643409 @default.
- W2771654882 hasRelatedWork W2997269586 @default.
- W2771654882 hasVolume "98" @default.
- W2771654882 isParatext "false" @default.
- W2771654882 isRetracted "false" @default.
- W2771654882 magId "2771654882" @default.
- W2771654882 workType "article" @default.